Staff Data Search - جامعة الزقازيق

Personal Website
Curriculum Vitae

Mo'men Mahmoud Ezzelarab Abdelaziz Metwally Askoura

Faculty pharmacy - Department Microbiology and Immunology Department

Scientific degrees

BSc In NULL, [2000]
MSc In NULL, [2005]
PhD In NULL, [2015]

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 5/10/2000
Doctor Assisant : 1/3/2006
Doctor : 28/3/2016
Professor Assisant : 27/4/2021
استاذ مساعد لقب علمى : 27/4/2021

Publications

1 - In Vitro Study on the Pathogenicity of Proteus Species Isolated

2 - efflux pump inhibitors epis as new antimicrobila agents against peseudomnas aeruginosa (2011).

3 - listeria monocytogenes internalins: a diverse proteinfam invoved in virulence (2010).

4 - The Campylobacter jejuni Ferric Uptake Regulator Promotes Acid Survival and Cross-Protection against Oxidative Stress. (2016).

5 - Functional insights into the interplay between DNA interaction and metal coordination in ferric uptake regulators (2018).

6 - Zinc oxide nanoparticles inhibits quorum sensing and virulence in Pseudomonas aeruginosa (2019).

7 - An innovative role for tenoxicam as a quorum sensing inhibitor in Pseudomonas aeruginosa (2019).

8 - Oxidative Stress Infuences Pseudomonas aeruginosa Susceptibility to Antibiotics and Reduces Its Pathogenesis in Host (2020).

9 - Investigating the inﬂuence of iron on Campylobacter jejuni transcriptome in response to acid stress (2019).

10 - Ciproloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression (2020).

11 - Characterization of φEf-vB1 prophage infecting oral Enterococcus faecalis and enhancing bacterial biofilm formation (2020).

12 - Characterization of Polyvalent Bacteriophages Targeting Multidrug-Resistant Klebsiella pneumonia with Enhanced Anti-Biofilm Activity (2021).

13 - Repositioning secnidazole as a novel virulence factors attenuating agent in Pseudomonas aeruginosa. (2018).

14 - Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (2021).

15 - Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (2021).

16 - Evaluation of the Effectiveness of Soil Streptomyces Isolates for Induction of Plant Resistance Against Tomato mosaic virus (ToMV) (2021).

17 - Exploring Staphylococcus aureus Virulence Factors; Special Emphasis on Staphyloxanthin (2021).

18 - A NEW ROLE OF METFORMIN AS AN EFFLUX PUMP INHIBITOR IN KLEBSIELLA PNEUMONIA (2021).

19 - Antibioflm and staphyloxanthin inhibitory potential of terbinafne against Staphylococcus aureus: in vitro and in vivo studies (2022).

20 - Zinc oxide nanoparticles reduce bioflm formation, synergize antibiotics action and attenuate Staphylococcus aureus virulence in host; an important message to clinicians (2022).

21 - Zinc oxide nanoparticles reduce bioflm formation, synergize antibiotics action and attenuate Staphylococcus aureus virulence in host; an important message to clinicians (2022).

22 - In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates (2022).

23 - Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach (2022).

24 - Inhibition of efflux pumps in Klebsiella pneumoniae isolated from patients with respiratory tract infection (2024).

25 - Isolation and Characterization of Bacteriophages Infecting Pseudomonas aeruginosa (2024).

26 - Determination of the role of staphyloxanthin in stress survival and pathogenesis of Staphylococcus aureus (2024).

27 - Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy (2023).

28 - Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae (2024).

29 - Evaluation of the antimicrobial activity of actinomycetes isolated from soil (2024).

30 - Isolation and characterization of bacteriophages targeting Escherichia coli (2024).

31 - Study on bacteriophages targeting Klebsiella pneumoniae causing nosocomial infections (2024).

32 - Study on anti-virulent agents targeting Escherichia coli (2024).

33 - Determination of the role of staphyloxanthin in stress survival and pathogenesis of Staphylococcus aureus (2024).

34 - Characterization of the influence of stress exposure on antibiotics susceptibility & pathogenesis of P. aeruginosa isolates (2024).

35 - Eradication of bacterial-biofilm isolated from patients with dental plaque and dental caries (2024).

36 - Study on resistance of clinical Klebsiella pneumoniae to carbapenem (2024).

37 - Isolation and characterization of bacteriophages targeting Klebsiella pneumoniae (2024).

38 - Screening and Characterization of Keratinolytic activity from Local Microbial Isolates. (2024).

39 - Study of the virulence potential of Candida spp isolated from different clinical sources (2024).

40 - Screening for some natural antifungal agents to control infection by candida albicans (2024).

41 - A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa (2023).

Research Area